Company Overview of Biotechnology General (Israel) Ltd.
Biotechnology General (Israel) Ltd. (BTG-Israel) manufactures and markets pharmaceutical products. The company offers Bio-Tropin, which is a recombinant human growth hormone; EUFLEXXA, a medical device containing fermentation-derived sodium hyaluronate for intra-articular injection into the knee for the treatment of joint pain due to osteoarthritis; Biolon, a medical device containing fermentation-derived sodium hyaluronate which is used as a viscoelastic aid in cataract and ophthalmic surgery. BTG-Israel was founded in 1980 and is based in Kiryat Malachi, Israel. Biotechnology General (Israel) Ltd. operates as a subsidiary of Ferring B.V.
Be'er Tuvia Industrial Area
Kiryat Malachi, 83104
Founded in 1980
972 8 861 2020
972 8 861 2154
Key Executives for Biotechnology General (Israel) Ltd.
Similar Private Companies By Industry
|FineTech Laboratories Ltd.||Middle East/Africa|
|Chemagis Ltd.||Middle East/Africa|
|DAN Immunotherapy Ltd.||Middle East/Africa|
|Scigen Israel Limited||Middle East/Africa|
|Teva Pharmaceutical Finance II LLC||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Biotechnology General (Israel) Ltd., please visit www.btgil.com. Company data is provided by Capital IQ. Please use this form to report any data issues.